Blood Cancer United Announces $7.5 Million Gift From Royalty Pharma to Expand Therapy Acceleration Program

Positive

AI Analysis

Summary

Royalty Pharma announced a $7.5 million donation to Blood Cancer United to expand its venture philanthropy program supporting therapy development, with returns reinvested to fund future therapies.

Importance:2/10

Sentiment:

0.60

philanthropyventure philanthropyblood cancertherapy accelerationdonation

Related Companies

$RPRX

Read the original article

Published by PR Newswire Biotech on September 15, 2026 8:30 PM

Read Original